Results 181 to 190 of about 152,669 (311)

Indications and Efficacy of Progestogen‐Monotherapy as Menopause Hormone Therapy: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen monotherapy, though historically underutilized, represents a viable alternative in this population. This narrative review
Chloe Thomas, Olivia Carere, Lauren Clarfield, Michelle Jacobson   +3 more
wiley   +1 more source

Ovarian borderline mucinous tumor with carcinosarcomatous mural nodule: a case report of a rare entity and review of the literature. [PDF]

Front Med (Lausanne)
Bai Y, Xia Y.
europepmc   +1 more source

Epithelial Ovarian Carcinoma: Analysis of Prognostic Factors

Yonsei Medical Journal, 1988
S N, Kim, T K, Park
openaire   +2 more sources

BRD9 inhibition as potential treatment option for testicular germ cell tumors

Andrology, EarlyView.
Abstract Background Testicular germ cell tumors (TGCT) are the predominant tumor in younger males. Usually, 5‐year survival rates are quite high, but 15–20% of patients with metastatic non‐seminomas are resistant to standard cisplatin‐based therapy.
Aylin Hansen, Christine Sanders, Florian Fronhoffs, Kai Funke, Glen Kristiansen, Hubert Schorle   +5 more
wiley   +1 more source

Predictive ability of novel glycovariant biomarkers of CA125 and CA15-3 up to three years prior to ovarian cancer diagnosis: a population-based case-control study. [PDF]

J Ovarian Res
Roos Alexander H, Afrin Ruma S, Jain S, Lundin E, Liv P, Israelsson P, Pettersson K, Idahl A.   +7 more
europepmc   +1 more source

Inhibition of HMGA2 Leads to Reduced Cell Proliferation and Increased Apoptosis in Human Embryonal Carcinoma Cell Lines

Andrology, EarlyView.
ABSTRACT Background The most prevalent solid tumors in young men are testicular germ cell tumors (TGCTs), and embryonal carcinoma is the most common subtype among non‐seminomatous germ cell tumors (NSGCTs). Despite the excellent cure rates of cisplatin‐based chemotherapy, resistance develops in 15%–30% of patients with metastatic cancer, which results ...
Marco De Martino, Matteo Lampitto, Alfredo Fusco, Marco Barchi, Francesco Esposito, Paolo Chieffi   +5 more
wiley   +1 more source

A Rare Case of Metachronous Clear Cell Ovarian Carcinoma and Thyroid Carcinoma: Clinical and Pathological Insights

Steven Ridwan, Ali Budi Harsono, Dodi Suardi, Andi Kurniadi, Kemala Isnainiasih Mantilidewi, Yudi Mulyana Hidayat Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Padjadjaran–Dr.
Kurniadi A, Ridwan S, Hidayat YM, Harsono AB, Suardi D, Mantilidewi KI   +5 more
core  

Two case reports of ovarian clear cell carcinoma with central necrosis representing a mille-feuille-like appearance on contrast-enhanced MRI. [PDF]

Radiol Case Rep
Takeyama N, Ueda Y, Tashiro Y, Miyamoto S, Sasaki Y, Nakayama K, Ogawa T, Wada A, Nakamura A, Kachi M, Tauchi M, Morioka M.   +11 more
europepmc   +1 more source

T Cell Microenvironmental Impacts and Therapeutic Opportunities: Application to Human Testicular Germ Cell Tumors

Andrology, EarlyView.
ABSTRACT Testicular germ cell tumors (TGCT) are the leading malignancy in adolescent and young adult males, yet the immunological and cellular mechanisms governing their tumor microenvironment (TME) remain poorly understood. Here, we present a comprehensive review of TGCT pathobiology with a focus on the immune landscape, particularly the role of tumor‐
R Islam, M Figura, J Heyer, S Lieber, M Huber, KL Loveland, HC Schuppe, Daniela Fietz   +7 more
wiley   +1 more source

Fertility-Sparing Surgery for Ovarian Mucinous Tumors and Risk of Recurrence. [PDF]

Cureus
Aslam M, Saqib A, Ahmed Y, Riaz A, Syed A.   +4 more
europepmc   +1 more source